Login

Invests, and empowers viable blockchain entrepreneurs, startups, and communities|Yi He,Co-Founder and Head of Ventures,Binance Labs 00:10:00

Share On Facebook Share On Twitter

Co-founder and CMO at Binance.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
We Invest in Market Leading Industrial and Consumer Businesses|Drew Davis,Director,Monomoy Capital Partners
00:10:00
Giving Back: Video Series Part 2 | Matt Roberts, Chief Planning Officer, Financial Planner of Syverson Strege
00:10:00
A Pioneer in Mental Health Investing|Amanda Eilian,Founding Partner,Able Partners
00:10:00
Morgan's adviser Chris Titley recently interviewed Vik Bansal, CEO of Cleanaway (ASX: CWY), who has been with the company since July, discussing his tenure and insights into the business.
00:10:00
Partners with exceptional entrepreneurs starting at the earliest stages of the climb|Erica Brescia,Managing Director,Redpoint
00:00:00
Highlights Genetic Technologies (NASDAQ: GENE) -Simon Morriss, CEO, Genetic Technologies Ltd
00:00:00
Science Matters with Jeremy Gunawardena / Jeremy Gunawardena Associate Professor of Systems Biology, HMS
00:10:00
From Sales Associate to Store Manager: A Journey of Growth and Customer Service Excellence
00:10:00
Graphite's Role in the Battery Value Chain: From Mining to Advanced Applications
00:10:00
Navigating Social Change and Investment: Insights from Paul Niven, Fund Manager at F&C Investment Trust
00:10:00
Committed to excellent standards of care|Wright Lassiter III,Chief Executive Officer, MHA
00:10:00
From Paper Routes to Financial Stewardship: Tim Harrison's Journey

© 2017 - Neuhu+